(WASHINGTON)—The American Society of Hematology (ASH) today announced the names of 15 promising medical students chosen to participate in its 2013 Minority Medical Student Award Program (MMSAP).
Each year the ASH MMSAP program provides a group of bright minority medical students with the unique opportunity to design and implement a hematology-related research project during an eight- to 12-week summer program. Each student participant is also paired with both a research and career-development mentor who assist them with the execution of their projects and offer career guidance throughout medical school and beyond. Medical students conduct research alongside their mentors studying topics ranging from deep-vein thrombosis and angiogenesis to lymphoma and multiple myeloma.
This career-development award program, offered to first- and second-year medical students from the United States and Canada in their DO, MD, or MD/PhD programs, is designed to spark minority medical students’ interest in the field of hematology. It is one of several initiatives under ASH’s Minority Recruitment Initiative, a program committed to increasing the number of minority medical scholars in hematology.
“The MMSAP demonstrates ASH’s commitment to promoting diversity in the field of hematology. ASH is proud to offer such a comprehensive, experiential learning opportunity to these students and connect them with inspiring mentors. I hope that for many, participation in this program will mark the beginning of a long, successful hematology research career,” said ASH President Janis L. Abkowitz, MD, of the University of Washington.
In addition to their participation in the MMSAP summer research program, participants will receive a $5,000 research stipend and travel allowance to attend the 55th ASH Annual Meeting in New Orleans where they will present their research. MMSAP participants also receive complimentary subscriptions to Blood and the Society member newsletter The Hematologist.
After completing the MMSAP program, students are invited to continue their involvement and are encouraged to apply to participate in an additional research opportunity in a subsequent year of medical school. ASH funds up to three second-experience participants each year.
The 2013 MMSAP award recipients are as follows:
- Gilbert M. Acevedo, University of Colorado School of Medicine
- Hewan Belete, University of Minnesota (Second-year participant)
- Aleshia Nichol Brewer-Lowry, Chicago Medical School
- Miguel Dario Cantu, The University of Texas Medical School at Houston
- Denzel Cole, Morehouse School of Medicine
- Sophia Harvey, Michigan State University College of Human Medicine
- Sarafina Kankam, University of Kansas School of Medicine
- Karen C. Manotas, The University of Utah
- Reilin J. Moore, Indiana University
- Joy Morgan, Howard University College of Medicine
- Jamaji Nwanaji-Enwerem, Harvard Medical School
- Osarhiemen Omwanghe, University of Illinois at Urbana-Champaign
- Manuel Ozambela, Harvard Medical School
- Lauren Patrick, University of Rochester School of Medicine and Dentistry
- Necrisha Roach, The Ohio State University College of Medicine
The ASH MMSAP program is one of several ASH career development award programs supported by the newly launched ASH Foundation (www.hematology.org/foundation). Through the generosity of donations from ASH members and supporters, the ASH Foundation is dedicated to moving hematology forward through research, education, and quality care by expanding the reach of successful ASH programs and developing new initiatives to address critical issues facing hematology researchers and clinicians. Visit www.hematology.org/foundation to learn more and to make a donation.
To arrange an interview with a MMSAP recipient, please contact Kaitlin Bressler, ASH Communications Associate, at 202-552-4925 or firstname.lastname@example.org
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.
back to top